Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“And I believe some have suggested that LG was in the UK for some time a few weeks back. Perhaps whatever those business activities LP was alluding to, they may involve the UK?”
“....if all those things do not warrant some news individually or all together by NWBO I will {be} shocked.”
One needs to be more than just vigilant when dealing with “unseasoned low price equities with little Wall St. sponsorship and low institutional ownership”
Speaking of Shorts - it is interesting to follow Weyland Tech’s (IHub message board WEYL) strategy to identify naked shorts…..those same scalawags that are suspect in victimizing NWBO. WEYL’s action was suggested to NWBO some time ago on our MB but, for whatever reason, was not adopted.
https://investorshub.advfn.com/Weyland-Tech-Inc-WEYL-9097/
Note:
Post #48555 - Letter sent to Finra (apparently following previous letters)
Post #48548 - Link to banks/brokers who have yet to respond with requested list even though deadline was Nov. 2nd.
Post #48577 - Ouch!!
“I am in the process of selling my 5,000 sq ft home so my wife and I can downsize to 2 lake houses about 1,500 sq ft each... one a summer home in the U.P. of Michigan, the other a winter home in Alabama... “
“All you people here are just writers for the ongoing soap opera. You don't want anything to end and certainly don't want to challenge leadership or Woodford. That's obvious by the way any idea to standup for yourselves gets ignored. The game here is to keep retail engaged.
It's all a lie. I'm done here.”
He’s doing great Doc Logic. He’s been to 6 rehab sessions now and he’s 6 weeks from his surgery. The rehab people are all super pleased with his progress as well. Best thing... he’s in no pain. Thank you so much for asking!
Will new dc vax direct data be presented by Dr. Q and colleagues october 18-20?https://clinicaltrials.gov/ct2/show/NCT03638765?term=northwest+biotherapeutics&rank=4
My wife told me to "Shut the Hell Up!!!" last night... is that significant???
Impressive!
Perhaps this has already been posted:
UCLA neurosurgeon named to National Academy of Medicine
https://cancer.ucla.edu/Home/Components/News/News/1198/1631
Senti and Flipper, I have always thought the game was fixed to some extent.
“Please post the papers that will be delivered on dc vax direct by Dr Q and others. by https://ce.mayo.edu/neurology-and-neurologic-surgery/content/mayo-clinic-neuroscience-and-oncology-innovation-summit-2018#group-tabs-node-course-default2 “
Opps! my error. A common mistake. I read BlackRock in my mind and not in my eyes. Thanks Longfellow, I should know better.
https://www.cnbc.com/2017/06/22/blackstone-or-blackrock-schwarzman-and-fink-did-it-on-purpose.html
Cognate Bioservices - part of Blackstone’s portfolio:
Firm Announces Launch of Blackstone Life Sciences Investment Platform
https://www.blackstone.com/media/press-releases/article/blackstone-announces-agreement-to-acquire-clarus-a-leading-life-sciences-investment-firm
Congrats to Nobel 2018 Laureates Dr. James Allison and Dr. Tasuku Honjo -- particularly because their discoveries led to clinical results for some patients that would not have otherwise made it. Now hopefully, further research like that of UCLA and NWBO on Dendritic cells will bring to fruition Nobel Laureates Ralph Steinman's and Zanvil's Cohn's discovery so that more patients can be treated.
Note to Mayo Clinic thread……
John Noseworthy, M.D., President & CEO, Mayo Clinic (Rochester Mn.) is retiring at the end of this year. Gianrico Farrugia, M.D., Vice President, Mayo Clinic, and CEO of Mayo Clinic Florida (Jacksonville) has been named as his successor.
Here is some background on Dr. Kai Chaichana:
background on Dr. Kai Chaichana
Mayo Clinic Neuroscience and Oncology Innovation Summit 2018
Key Biscayne, FL USOctober 18, 2018 to October 20, 2018
Dr. Alredo Quinones-Hinojosa - “Future Therapies GBM”
Dr. Kai Chaichana - “DC-Vax”
https://ce.mayo.edu/neurology-and-neurologic-surgery/content/mayo-clinic-neuroscience-and-oncology-innovation-summit-2018#group-tabs-node-course-default2
Again, we need to drain the swamp.
“No more postponement of the combo trial. Direct and Prostate trials resume. NICE confirmation arrives in 3 weeks. These are my predictions as the time is very ripe now.”
I am sorry to hear of your husband’s emergency. May the kind words you always extend to others now be offered you for his returned health.
Has anybody figured out how to kill the stuffed french toast recipe video that plays every time I launch a new widow ?
Bigger financier? Didn't the CEO of Cognate say "stay tuned" and don't they have some really big money backers behind them? Would Linda like to be a key holder of a combined research and manufacturing company that she brought into existence for the purpose of finding cancer cures? Will NWBO, or at least DCVax-L, have the opportunity to be independently valued by each potential cancer indication, ie all operable cancers, if this Phase 3 is successful and there is graduated success found based on improvements made during the course of the trial? Interesting potential considerations developing here along the path to "commercialization". Didn't the CEO at Cognate mention something about commercialization readiness? I dunno about Linda saying "stay tuned" anymore but when another CEO says it after just buying the manufacturing arm for DCVax I kind of want to look in that direction once in a while.
Novartis’ CAR-T Kymriah gets green light in England
http://www.pmlive.com/pharma_news/novartis_car-t_kymriah_gets_green_light_in_england_1251386?platform=hootsuite
Reference: The responses and discussions being brought forward as a result of the Cognate/FloDesign Sonics PR - much of it above my understanding. However, I did come across an interview with principals of FloDesign Sonics that may be of interest to some
Spotlight Interview by Insights.Bio:……pgs. 337-344 (3/4 down the page)
Stanely Kowalski III, Co-Founder, Chairman & CEO, FloDesign Sonics, USA
Daniella Kranjac, Co-Founder and Managing Director, Dynamk Capital LLC, USA
Member of the Board of Directors, FloDesign Sonics, USA
http://insights.bio/wp-content/uploads/sites/2/2018/05/0404%20CAR-T%20Spotlight%202018.pdf
Cool promo video for Flodesign Sonics:
Cells act (allign) differently to sound based on their structure so the question is does this purification process help improve existing cellular purification processes being utilized or in development for use with DCVax products. I don't know the answer to that question yet but for Cognate to pick up this technology for use with their product mix indicates that this process is selective enough for at least some of the applications they want to use it in and may be simpler and more cost effective.
To those learned posters who understand the DCVax science: Is Acoustic Cell Processing (ACP) platform applicable to the NWBO products? I ask because of the Cognate press release today and am aware that Cognate has a number of gene and cell therapy clients in addition to NWBO.
Cognate/FloDesign Sonics announcement:
https://www.cognatebioservices.com/cognate-bioservices-flodesign-sonics-announce-collaboration-advance-acoustic-cell-processing-platform-cell-therapy-manufacturing/
Yet another reason the UK/NWBO might be potentially inclined to initiate DCVax-L launch in UK first*. MHRA assessment of therapeutics for UK (and only the UK) might be the ticket to a sane ramp. EMA assessment and distribution could follow thereafter.
(* If the trial is successful)
EMA ends drug assessments in UK
https://www.firstwordpharma.com/node/1588592?tsid=28®ion_id=6
Is NWBO ready for early approval with manufacturing? Cognate seems to be hinting strongly at this right?
Imagine how fast Direct might be approved if massive amounts of TILs and tumor necrosis is detected early on along with improved quality of life. Is NWBO ready for early approval with manufacturing? Cognate seems to be hinting strongly at this right?
Is NWBO caught in the abyss of a changing FDA?
“I’d like to use this opportunity to reflect on how the FDA is creating a new operating system for innovation by modernizing clinical trials, streamlining the FDA’s organization and processes to advance regulatory science, and expanding the FDA’s capacity to analyze complex real-world data streams to detect early safety and efficacy signals. And to describe the new policies we plan to announce to advance these goals.” Scott Gottlieb
“As part of these efforts, the FDA is also actively working to evaluate the use of real-world evidence (RWE) to support regulatory decisions.” Scott Gottlieb
Most excellent
Thank you
“Thanks for the quality posts DocLogic They are appreciated more than you can tell by the responses... or lack of responses.
If you could upvote here the appreciation we feel would be more obvious.
Cheers and good luck”
Woodford’s recent comments on Patient Capital Fund. NWBO is one of the holdings in this fund although not mentioned. The article highlights Woodford’s sentiment with this investment:
Woodford says: ‘We are investing in businesses we think will change the world and this is the most attractive asset class I have ever looked at, analysed or invested in.’
The star investor accuses the UK fund management industry of treating early-stage science and technology companies like a ‘leper colony’.
John McCain has passed away.
My response to your PM message to me to post full article Global Update on the Cell & Gene Therapy Regulatory Landscape: Sorry, ae, I was unable to access full article myself as I am not registered nor have a membership with Insight Bio.